Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 20, 2017
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
[ Fri, Oct 20th 2017
] - WOPRAI
Thu, October 19, 2017
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
David Buck Initiated (SUPN) at Strong Buy and Held Target at $53 on, Oct 19th, 2017
David Buck of FBR Capital, Initiated "Supernus Pharmaceuticals, Inc." (SUPN) at Strong Buy and Held Target at $53 on, Oct 19th, 2017.
David has made no other calls on SUPN in the last 4 months.
There are 3 other peers that have a rating on SUPN. Out of the 3 peers that are also analyzing SUPN, all agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Annabel Samimy of "Stifel" Downgraded from Strong Buy to Hold on, Tuesday, September 19th, 2017
- David Amsellem of "Piper Sandler" Downgraded from Buy to Hold on, Monday, July 17th, 2017
- Ken Trbovich of "Janney Montgomery Scott" Initiated at Hold and Held Target at $47 on, Friday, July 14th, 2017
